Dr. W. John Martin is the Medical Director of MI Hope, a non-profit public charity, formed in 1988 to support those with mental illness. He received his medical degree from the University of Sydney, Australia and the degree from the University of Melbourne. He has Boards in Anatomic and in Clinical Pathology with subspecialty qualifications in Immunopathology and in Medical Microbiology.
Dr. Martin has pioneered research leading to the detection of viruses, which are not normally recognized by the cellular immune system and, therefore, do not cause inflammation. He coined the term stealth adapted viruses. Using virus cultures and molecular methods he was able to detect these viruses in many patients with neurological and psychiatric illnesses. Dr. Martin reported in 1995 that certain stealth adapted viruses were originally derived from the viruses in the types of monkeys used to produce poliovirus vaccines. Dr. Martin was well aware of this possibility having previously worked as the Chief of the Virus Oncology Laboratory within the United States Food and Drug Administration (FDA).
Continued research on stealth adapted viruses led to the identification of a potent, non-immunological anti-virus defense mechanism. It is mediated by the alternative cellular energy (ACE) pathway and is effective in suppressing both stealth adapted and more conventional viruses.
KELEA (Kinetic Energy Limiting Electrostatic Attraction) powers the ACE pathway.
